Pioneering diagnostics
E.g., 25/12/2019
E.g., 25/12/2019

bioMérieux and the Fleming Fund: working together to strengthen diagnostic capacity and tackle antimicrobial resistance in low- and middle-income countries

18 December, 2019

London (UK), Marcy l’Étoile (France) – December 18, 2019 – bioMérieux, a world leader in in vitro diagnostics which develops and manufactures testing solutions (systems, reagents, software, services) mainly used for diagnosing infectious diseases, has been selected...

Third-Quarter 2019 Business Review

22 October, 2019

  • Organic growth of 6.8% at constant exchange rates and scope of consolidation over the first nine months of the year:
    • €1,928 million in sales 
    • Up 10.3% as...

First-Half 2019 Results

04 September, 2019

bioMérieux – First-Half 2019 Results


  • Organic sales growth of 5.5% for first-half 2019:
    • €1,275 million in sales
    • Up 9.1% as reported
  • As expected...

bioMérieux increases its holding in Hybiome from 54% to 67%

06 June, 2019

bioMérieux, a world leader in the field of in vitro diagnostics, today announced an increase of its shareholding in Suzhou Hybiome Biomedical Engineering Co. Ltd. This announcement follows the earlier announcement of the acquisition of a majority stake in this...

NEPHROCHECK Biomarkers TIMP-2 and IGFBP7 Included in the ERAS “Guidelines for Perioperative Care in Cardiac Surgery”

13 May, 2019

The NEPHROCHECK® Test biomarkers (TIMP-2 and IGFBP7) that indicate kidney stress in advance of acute kidney injury (AKI) have been included in the “Guidelines for Perioperative Care in Cardiac Surgery” which were published by the ERAS® (Enhanced Recovery After...

bioMérieux – First-Quarter 2019 Business Review

24 April, 2019

  • Organic growth of 3.8% (at constant exchange rates and scope of consolidation)

    • €632 million in sales

    • Up 7.7% as...

“Global-PPS”, a survey of antibiotic use and bacterial resistance in hospitals worldwide, tops the 200,000 patients  

15 April, 2019

 bioMérieux, a world leader in the field of in vitro diagnostics, and the Laboratory of Medical Microbiology at the University of Antwerp announced at ECCMID (European Congress of Clinical Microbiology & Infectious Diseases) the 2018 results of the Global Point...

University of Antwerp, bioMérieux, and Wellcome Trust to coordinate VALUE-Dx, a European Public-Private Partnership to fight antimicrobial resistance through diagnostics

02 April, 2019

Antwerp (Belgium), London (UK), Marcy l’Etoile (France) – April 1, 2019 - The University of Antwerp, bioMérieux and Wellcome Trust today announced the launch of VALUE-Dx, the first Innovative Medicines Initiative (IMI) project initiated by six in vitro...

Baxter and bioMérieux announce collaboration to improve identification and treatment of acute kidney injury

19 March, 2019

Baxter International Inc. (NYSE:BAX), a global leader in acute care, and bioMérieux, a world leader in the field of in vitro国产微拍福利 diagnostics, announced an agreement to develop future biomarkers with the goal to rapidly identify and inform treatment of acute kidney injury (AKI). The...

bioMérieux – 2018 Financial Results

27 February, 2019

  • Organic sales growth of 9.9% for full-year 2018:
    • €2,421 million in sales
    • Up 5.8% as reported
    • Solid fourth-quarter performance, with organic growth of more than 10%
  • Improvement in...